Advertisement
U.S. markets closed

OptimizeRx Corporation (OPRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
12.150.00 (0.00%)
At close: 04:00PM EDT
12.33 +0.18 (+1.48%)
After hours: 06:45PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Previous Close12.15
Open11.78
Bid12.09 x 200
Ask12.20 x 100
Day's Range11.65 - 12.40
52 Week Range6.92 - 16.65
Volume416,865
Avg. Volume121,931
Market Cap220.553M
Beta (5Y Monthly)1.00
PE Ratio (TTM)N/A
EPS (TTM)-0.81
Earnings DateMay 08, 2024 - May 13, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est16.40
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for OPRX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • OptimizeRx Corporation
    OPRX: Lowering target price to $10.00OPTIMIZERX CORP has an Investment Rating of SELL; a target price of $10.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    last yearArgus Research
View more
  • GlobeNewswire

    OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET

    WALTHAM, Mass., March 25, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and patients, will hold a conference call on Thursday, March 28, 2024, at 8:30 a.m. Eastern Time to discuss the preliminary, unaudited results for the fourth quarter. OptimizeRx management will host the call, followed by a question-and-answer period. Details for t

  • GlobeNewswire

    OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023

    WALTHAM, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and patients, today provided an update on the anticipated timeline for its financial reporting and reaffirms prior revenue and adjusted EBITDA estimates for FY2023. The Company is working to complete its year end close and audit processes by the filing deadline fo

  • GlobeNewswire

    OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort

    Empowering healthcare providers to remove barriers to careWALTHAM, Mass., March 04, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced its collaboration with Walmart to support its Specialty Pharmacies of the Community (SPOCs) provider outreach initiative. OptimizeRx’s Dynamic Audience Activation Platform (DAAP